Volume 59, Issue 2, Pages (February 2001)

Slides:



Advertisements
Similar presentations
Volume 59, Issue 5, Pages (May 2001)
Advertisements

Volume 62, Pages S12-S22 (December 2002)
Volume 66, Issue 4, Pages (October 2004)
Volume 60, Issue 3, Pages (September 2001)
Volume 73, Issue 11, Pages (June 2008)
Volume 79, Issue 11, Pages (June 2011)
Volume 69, Issue 6, Pages (March 2006)
Volume 67, Issue 5, Pages (May 2005)
Volume 68, Issue 2, Pages (August 2005)
Volume 69, Issue 1, Pages (January 2006)
Volume 80, Issue 6, Pages (September 2011)
Lack of evidence of blood pressure-independent protection by renin-angiotensin system blockade after renal ablation  Anil K. Bidani, M.D., Karen A. Griffin,
Volume 64, Pages S27-S32 (October 2003)
Bax and Bak have critical roles in ischemic acute kidney injury in global and proximal tubule–specific knockout mouse models  Qingqing Wei, Guie Dong,
Organogenesis of the endocrine pancreas
Volume 79, Issue 11, Pages (June 2011)
Volume 67, Issue 3, Pages (March 2005)
Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells  Guillermo Villegas, Bäerbel Lange-Sperandio,
Volume 55, Issue 6, Pages (June 1999)
Volume 78, Issue 8, Pages (October 2010)
IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy  J.-A. Moon,
Volume 68, Issue 2, Pages (August 2005)
Volume 75, Issue 3, Pages (February 2009)
Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats  Julie Chao, Jenny J. Zhang, Kuei-Fu Lin,
Volume 67, Issue 2, Pages (February 2005)
Epidermal growth factor receptor inhibition attenuates early kidney enlargement in experimental diabetes  Lesley Wassef, Darren J. Kelly, Richard E. Gilbert 
Volume 61, Issue 1, Pages (January 2002)
Vitamin E attenuates crystal formation in rat kidneys: Roles of renal tubular cell death and crystallization inhibitors  H.-S. Huang, J. Chen, C.-F. Chen,
Volume 58, Issue 2, Pages (August 2000)
Volume 73, Issue 4, Pages (February 2008)
Volume 59, Issue 5, Pages (May 2001)
Karl A. Nath, Anthony J. Croatt, Jill J. Haggard, Joseph P. Grande 
Volume 63, Issue 5, Pages (May 2003)
Volume 63, Issue 2, Pages (February 2003)
Prenatal programming of adult hypertension in the rat
Volume 60, Issue 3, Pages (September 2001)
The Loss of MCP-1 Attenuates Cutaneous Ischemia–Reperfusion Injury in a Mouse Model of Pressure Ulcer  Yuki Saito, Minoru Hasegawa, Manabu Fujimoto, Takashi.
Volume 57, Issue 3, Pages (March 2000)
Volume 58, Issue 6, Pages (December 2000)
Tight blood pressure control decreases apoptosis during renal damage
Volume 77, Issue 4, Pages (February 2010)
Volume 83, Issue 3, Pages (March 2013)
Akito Maeshima, Yoshihisa Nojima, Itaru Kojima  Kidney International 
Volume 75, Issue 2, Pages (January 2009)
Volume 66, Issue 4, Pages (October 2004)
Wei-Zhong Ying, Pei-Xuan Wang, Paul W. Sanders  Kidney International 
Volume 55, Issue 3, Pages (March 1999)
Volume 60, Issue 6, Pages (December 2001)
The pathological role of Bax in cisplatin nephrotoxicity
Volume 76, Issue 7, Pages (October 2009)
B. Li, T. Morioka, M. Uchiyama, T. Oite  Kidney International 
Volume 65, Issue 6, Pages (June 2004)
Early and persistent activation of myocardial apoptosis, bax and caspases: insights into mechanisms of progression of heart failure  Gordon W Moe, George.
Attenuation of UVB-Induced Sunburn Reaction and Oxidative DNA Damage with no Alterations in UVB-Induced Skin Carcinogenesis in Nrf2 Gene-Deficient Mice 
Volume 61, Issue 3, Pages (March 2002)
Volume 59, Issue 5, Pages (May 2001)
Resistance of mTAL Na+-dependent transporters and collecting duct aquaporins to dehydration in 7-month-old rats  Hassane Amlal, Catherine Wilke  Kidney.
M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang 
Volume 63, Issue 5, Pages (May 2003)
Volume 61, Issue 4, Pages (April 2002)
Volume 56, Issue 6, Pages (December 1999)
Volume 68, Issue 5, Pages (November 2005)
Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure  D.W. Johnson, B. Pat, D.A. Vesey, Z.
Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
Volume 58, Issue 6, Pages (December 2000)
Volume 75, Issue 5, Pages (March 2009)
A sphingosine-1-phosphate type 1 receptor agonist inhibits the early T-cell transient following renal ischemia–reperfusion injury  L.-W. Lai, K.-C. Yong,
Keratinocyte-Derived Granulocyte-Macrophage Colony Stimulating Factor Accelerates Wound Healing: Stimulation of Keratinocyte Proliferation, Granulation.
Eric N Haugen, Anthony J Croatt, Karl A. Nath  Kidney International 
Presentation transcript:

Volume 59, Issue 2, Pages 645-653 (February 2001) Different effects of angiotensin II and catecholamine on renal cell apoptosis and proliferation in rats  Toru Aizawa, Nobukazu Ishizaka, Kiyoshi Kurokawa, Ryozo Nagai, Hiroyoshi Nakajima, Jun-Ichi Taguchi, Minoru Ohno  Kidney International  Volume 59, Issue 2, Pages 645-653 (February 2001) DOI: 10.1046/j.1523-1755.2001.059002645.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Effect of continuous infusion of angiotensin II (Ang II) on blood pressure and expression of apoptosis-related proteins. (A) Time course of systolic blood pressure in Ang II-infused rats (N = 9). Ang II was continuously infused at a rate of 0.7 mg/kg/day for the indicated number of days. (B, C, E, and F) Effects of angiotensin II (Ang II) on apoptosis-related protein expression. After Ang II was infused for specified time periods, the kidneys were harvested, and the expression of bax (B and E) and bcl-2 (C and F) was examined. (B and C) Data from five to seven animals are summarized in the bar graphs. (D and E) Representative immunoblots. (F) Coomassie brilliant blue stained sodium dodecyl sulfate-polyacrylamide gels of protein samples from the kidneys of rats that had received continuous angiotensin II infusions for the indicated number of days. The same samples were used for the representative pictures of immunoblot analysis of bax and bcl-2 expression and Coomassie brilliant blue staining. *P < 0.05 and †P < 0.01 vs. controls, respectively. Kidney International 2001 59, 645-653DOI: (10.1046/j.1523-1755.2001.059002645.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 Localization of bax and heme oxygenase-1 (HO-1). (A) Hematoxylin-eosin staining of the kidneys of Ang II-induced hypertensive rats. (B–I) Bax and HO-1 staining were performed on serially sectioned specimens. Bax (B and C) and HO-1 (D and E) staining in the kidney of Ang II-induced hypertensive rats. The majority of the bax-positive cells were also positive for HO-1 with some discrepancies (arrows in D and asterisks in E). Bax (F and G) and HO-1 (H and I) staining in the kidneys of normotensive rats. Kidney International 2001 59, 645-653DOI: (10.1046/j.1523-1755.2001.059002645.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 3 Effects of antihypertensive drugs, subpressor doses of angiotensin II (Ang II) and norepinephrine (NE) on apoptosis-related protein expression. (A, left) Effects of losartan (Los) and hydralazine (Hyd). Losartan completely blocked Ang II-induced bax up-regulation, while hydralazine only partially blocked such an up-regulation. (Right) Effects of NE and a subpressor dose of Ang II (0.25 mg/kg/day). NE infusion did not increase renal bax expression. (B) Effect of vasopressors and vasodilators on bcl-2 expression in the kidney. Expression of bcl-2 in each group displays a relatively large variation, and neither vasopressors nor vasodilators significantly alter the bcl-2 expression within the kidney. (A and B, upper panels) Representative immunoblots. (A and B, lower panels) Data from four to six animals are summarized in a bar graph. *P < 0.01 vs. sham-operated controls; †P < 0.05 vs. Ang II-infused rats. Kidney International 2001 59, 645-653DOI: (10.1046/j.1523-1755.2001.059002645.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 4 Representative photographs of TUNEL-positive cells in the kidney of rats receiving either angiotensin II (Ang II) or norepinephrine (NE). (A–F) TUNEL staining. (A and D) Kidney specimen of the control rat. (B and E) Kidney specimen of the rat infused Ang II for seven days. Several TUNEL-positive nuclei were observed (arrows in B). Higher magnification showed that positive TUNEL staining was seen in both tubular (arrow in E) and interstitial (arrowhead in E) regions. (C and F) Kidney specimen of the rat infused NE for seven days. (G–L) PCNA immunohistochemistry. (G and J) Kidney specimen of the control rat. (H and K) Kidney specimen of the rat infused Ang II for three days. Several PCNA-positive nuclei were observed. (I and L) Kidney specimen of the rat infused NE for three days. D, E, F, J, K, and L are magnified views of bracketed regions in A, B, C, G, H, and I, respectively. Original magnifications are ×250 (A–C and G–I) and ×800 (D–F and J–L). Kidney International 2001 59, 645-653DOI: (10.1046/j.1523-1755.2001.059002645.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 5 Ang II-induced DNA fragmentation of the kidneys of rats receiving vasopressors and/or vasodilators. Genomic DNA samples purified from the kidney of rats receiving the indicated drug(s) were loaded onto 1.5% agarose gel. (A) Rats were continuously infused pressor doses (0.7 mg/kg/day) of Ang II for seven days with or without receiving vasodilators. Losartan completely inhibited the “ladder” formation induced by continuous Ang II infusion. (B) Subpressor doses (0.25 mg/kg/day) of Ang II or NE did not result in DNA ladder formation. Kidney International 2001 59, 645-653DOI: (10.1046/j.1523-1755.2001.059002645.x) Copyright © 2001 International Society of Nephrology Terms and Conditions